about
Effect of trandolapril on regression of retinopathy in hypertensive patients with type 2 diabetes: a prespecified analysis of the benedict trial.Effects of combined ezetimibe and simvastatin therapy as compared with simvastatin alone in patients with type 2 diabetes: a prospective randomized double-blind clinical trial.Preventing microalbuminuria in type 2 diabetes.Glomerular hyperfiltration and renal disease progression in type 2 diabetes.Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes.PERS&O (PERsistent Sitagliptin treatment & Outcomes): observational retrospective study on cardiovascular risk evolution in patients with type 2 diabetes on persistent sitagliptin treatment.ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapy.A Prospective Study for Introducing Insulin Pens and Safety Needles in a Hospital Setting. The SANITHY Study.Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICTSkin Oil Staining to Avoid Infusion Set Cannula Crimping: A Personal Observation.The GFR and GFR decline cannot be accurately estimated in type 2 diabetics.Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial.Bent needles: another problem in glycemic control.Comment on Muraki et al. Potato Consumption and Risk of Type 2 Diabetes: Results From Three Prospective Cohort Studies. Diabetes Care 2016;39:376-384.Efficacy, safety and acceptability of the new pen needle 33G × 4 mm. AGO 01 study.Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes MellitusEffects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trialSide-effects, structure, and H2-receptor antagonistsAno-rectal manometry as an evaluating test for impaired ano-rectal function in diabetes mellitusEpidural spinal electrostimulatory system (ESES) in the management of diabetic foot and peripheral arteriopathiesClinical and instrumental diagnosis of autonomic neuropathy in insulin-dependent diabetesOndasentron in the treatment of diabetic diarrheaScintigraphic assessment of pituitary adenomas and several diseases by indium-111-pentetreotideGLP-1 response to 2 energy-matched snacks[The SAVOR-TIMI 53 study]Pasta Consumption and Connected Dietary Habits: Associations with Glucose Control, Adiposity Measures, and Cardiovascular Risk Factors in People with Type 2 Diabetes-TOSCA.IT StudyLack of Efficacy of SGLT2-i in Severe Pneumonia Related to Novel Coronavirus (nCoV) Infection: No Little Help from Our Friends
P50
Q33982971-FD3AA7D8-980A-4515-A250-93BF0586B783Q34084495-CEC07FC5-58DB-46D3-83EB-7E0FB330602EQ34552302-1BA0EF4A-BBF0-4A9E-B86B-4CA893032A2FQ36249519-C05D2F34-927D-455E-9FC1-D6B65E89A200Q36280369-86B71235-80AF-4441-975A-4A2FA7F0A180Q37101005-69700C14-039D-4D98-A423-49F90BC01844Q37193285-79422E3E-56FD-4647-B70B-CAB21DC21647Q37419552-5695412F-D00E-4489-B4B7-40B98C32B9D3Q37429216-3BE10488-DB68-4C54-9117-AAF296A8FEB9Q42392244-AF11FB63-3F5E-4BCF-92F3-9ACABAD52595Q43588428-528E7806-ACC1-4904-AE48-00F18DE62285Q44392807-D7CB78A4-F95E-4AD1-96D0-B252449AEBCBQ46344361-D45E4082-15E1-4DDD-B8EE-96021B447C0BQ48098524-D4129B71-962F-4FAF-B884-9C3F0E041711Q51311527-A2EF84C4-DFFF-4451-A498-0BAED34BE48FQ57701995-F5CD3AE6-0EB5-4714-B13F-A9286AFBC475Q57702064-B404AE40-2CA1-4949-9DF6-0A77C803BC14Q67516533-DD7AF18B-E30A-4B68-A388-95B4D66D65A8Q68978886-A3CE3CD7-5A4F-4603-826B-53A3EAA30228Q69066816-1EF670E8-1AAC-4CEA-A9DD-9836D8FBA2ABQ70621440-A62FD5E1-4026-4070-8350-BA2763A80539Q72133591-04715A41-8A8A-40D4-8F29-50945884790CQ72995323-56C4A570-41B7-4750-A4AE-F3F33D6C76C6Q85834436-94A29E7C-98EF-41CF-8A45-649C7FA39A18Q87464614-12958BE8-1861-4BCF-A995-88A81DB88700Q92443182-4ABB9EF6-DF0A-41D0-85C4-7F7D70521EF8Q95650297-79164973-6C61-4987-9862-D8114ED817F7
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-8900-1787
@en
name
Antonio Bossi
@ast
Antonio Bossi
@en
Antonio Bossi
@es
Antonio Bossi
@nl
type
label
Antonio Bossi
@ast
Antonio Bossi
@en
Antonio Bossi
@es
Antonio Bossi
@nl
prefLabel
Antonio Bossi
@ast
Antonio Bossi
@en
Antonio Bossi
@es
Antonio Bossi
@nl
P106
P21
P31
P496
0000-0001-8900-1787